Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fitim Berisha

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pathology Oncology Research : POR|July 16, 2025
The implications of abnormal signal patterns of break-apart FISH probes used in the diagnosis of bone and soft tissue tumoursHongtao Ye, Fitim Berisha, Evie Rowles, et al.
Skeletal Radiology|February 6, 2013
Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five casesM Fernanda Amary, Paul O'Donnell, Fitim Berisha, et al.
Histopathology|February 5, 2016
The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastomaM Fernanda Amary, Fitim Berisha, Rafael Mozela, et al.
Virchows Archiv : an International Journal of Pathology|April 4, 2015
Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatosesSarah J Aitken, Nadège Presneau, Sangeetha Kalimuthu, et al.
The American Journal of Surgical Pathology|May 16, 2017
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of BoneFernanda Amary, Fitim Berisha, Hongtao Ye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2009
GNAS1 mutations occur more commonly than previously thought in intramuscular myxomaDavid Delaney, Tim C Diss, Nadege Presneau, et al.
The American Journal of Surgical Pathology|September 7, 2019
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic ToolFernanda Amary, Eva Markert, Fitim Berisha, et al.
The Journal of Pathology|August 1, 2012
An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordomaAndrew C Nelson, Nischalan Pillay, Stephen Henderson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2007
Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcomaMaria Fernanda C Amary, Fitim Berisha, Fabiola Del Carlo Bernardi, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesisRoberto Jose Diaz, Mustafa Guduk, Rocco Romagnuolo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pathology Oncology Research : POR|July 16, 2025
The implications of abnormal signal patterns of break-apart FISH probes used in the diagnosis of bone and soft tissue tumoursHongtao Ye, Fitim Berisha, Evie Rowles, et al.
Skeletal Radiology|February 6, 2013
Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five casesM Fernanda Amary, Paul O'Donnell, Fitim Berisha, et al.
Histopathology|February 5, 2016
The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastomaM Fernanda Amary, Fitim Berisha, Rafael Mozela, et al.
Virchows Archiv : an International Journal of Pathology|April 4, 2015
Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatosesSarah J Aitken, Nadège Presneau, Sangeetha Kalimuthu, et al.
The American Journal of Surgical Pathology|May 16, 2017
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of BoneFernanda Amary, Fitim Berisha, Hongtao Ye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2009
GNAS1 mutations occur more commonly than previously thought in intramuscular myxomaDavid Delaney, Tim C Diss, Nadege Presneau, et al.
The American Journal of Surgical Pathology|September 7, 2019
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic ToolFernanda Amary, Eva Markert, Fitim Berisha, et al.
The Journal of Pathology|August 1, 2012
An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordomaAndrew C Nelson, Nischalan Pillay, Stephen Henderson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2007
Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcomaMaria Fernanda C Amary, Fitim Berisha, Fabiola Del Carlo Bernardi, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesisRoberto Jose Diaz, Mustafa Guduk, Rocco Romagnuolo, et al.
Pageof 2